“Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model”. International Journal of Environmental Sciences, vol. 11, no. 12s, June 2025, pp. 1360-7, https://doi.org/10.64252/8crhea08.